Phase 1 trials of rVSV Ebola vaccine in Africa and Europe
ST Agnandji, A Huttner, ME Zinser… - … England Journal of …, 2016 - Mass Medical Soc
Background The replication-competent recombinant vesicular stomatitis virus (rVSV)–based
vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety …
vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety …
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.
ST Agnandji, A Huttner, ME Zinser… - The New England …, 2015 - europepmc.org
Background The replication-competent recombinant vesicular stomatitis virus (rVSV)-based
vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety …
vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety …
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
ST Agnandji, A Huttner, ME Zinser… - The New England …, 2016 - pubmed.ncbi.nlm.nih.gov
Background The replication-competent recombinant vesicular stomatitis virus (rVSV)-based
vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety …
vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety …
Phase 1 trials of rVSV ebola vaccine in Africa and Europe
ST Agnandji, A Huttner… - New England …, 2016 - tobias-lib.ub.uni-tuebingen.de
Phase 1 trials of rVSV ebola vaccine in Africa and Europe Phase 1 trials of rVSV ebola
vaccine in Africa and Europe DSpace Repositorium (Manakin basiert) Einloggen …
vaccine in Africa and Europe DSpace Repositorium (Manakin basiert) Einloggen …
Phase 1 trials of rVSV ebola vaccine in Africa and Europe
ST Agnandji, A Huttner, ME Zinser… - … England Journal of …, 2016 - ub01.uni-tuebingen.de
Phase 1 trials of rVSV ebola vaccine in Africa and Europe Phase 1 trials of rVSV ebola
vaccine in Africa and Europe DSpace Repositorium (Manakin basiert) Einloggen …
vaccine in Africa and Europe DSpace Repositorium (Manakin basiert) Einloggen …
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
ST Agnandji, A Huttner… - New England …, 2016 - researchinformation.amsterdamumc …
BACKGROUND The replication-competent recombinant vesicular stomatitis virus (rVSV)-
based vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid …
based vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid …
Phase 1 trials of rVSV Ebola vaccine in Africa and Europe.
ST Agnandji, A Huttner, ME Zinser, P Njuguna… - 2016 - cabidigitallibrary.org
BACKGROUND: The replication-competent recombinant vesicular stomatitis virus (rVSV)-
based vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid …
based vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid …
[HTML][HTML] Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
ST Agnandji, A Huttner, ME Zinser… - The New England …, 2016 - ncbi.nlm.nih.gov
Background The replication-competent recombinant vesicular stomatitis virus (rVSV)–based
vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety …
vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety …
[PDF][PDF] Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
S Agnandji, A Huttner, M Zinser, P Bejon - New England Journal of …, 2016 - ora.ox.ac.uk
BACKGROUND The replication-competent recombinant vesicular stomatitis virus (rVSV)–
based vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid …
based vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid …
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.
ST Agnandji, A Huttner, ME Zinser… - The New England …, 2016 - openaccess.sgul.ac.uk
BACKGROUND: The replication-competent recombinant vesicular stomatitis virus (rVSV)-
based vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid …
based vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid …